Higher morbidity found where fewer staffers are vaccinated against COVID-19
Information helps users decide when, and whether, to venture outside or exercise
Younger-patient mortality rate nearly triples, 20 years of data indicate
U.S. efforts to encourage transparency widely ignored by companies
Pharmaceutical companies are better able to identify promising new applications for existing drugs
When beds are limited, turning away the sickest and poorest boosts margins
Matt Schmitt’s research shows hospital prices rise after acquisitions, even where local competition is unchanged
The anti-infection procedure rises for a time, when workers are watched, and then falls off
Uninsured and insured both receive help; benefits are temporary
Showing cumulative cases — not day-to-day trends — could nudge people to avoid reckless behavior
Dedicated FDA staff guide companies during design of clinical trials
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
At the end of a night shift, empathy for patients’ hurting seems diminished
Smartphone GPS tracks staffers between facilities
False hope for instilling disease resistance and desirable traits?
Examining local-level plans and behavior to uncover drivers of failed compliance with expert advice